• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

February 25, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Draft Agenda

DoubleTree Hotel Bethesda and Executive Meeting Center
8120 Wisconsin Ave., Bethesda, MD 20814
February 25, 2011

DRAFT AGENDA

Topic: Strain Selection for the Influenza Virus Vaccine for the 2011-2012 Season

8:30 a.m.
Call to OrderChair
8:35
Administrative RemarksDon Jehn, M.S., FDA
8:45
IntroductionJerry Weir, Ph.D., FDA
8:55
U.S. Surveillance

Lisa Grohskopf, M.D., CDC

9:15
World Surveillance/Virus CharacterizationNancy Cox, Ph.D., CDC
10:00
DoD Vaccine Effectiveness ReportKevin Russell, M.D., DOD
10:20
Break 
10:35
Vaccine Responses

Zhiping Ye, M.D., Ph.D., FDA

10:55
Availability of Vaccine Viruses & ReagentsWilliam McCormick, Ph.D., FDA
11:10
Comments from Manufacturers

Samson Lee, Ph.D.,
Sanofi Pasteur

11:30

Update on H5N1 and H9N2 Surveillance and Virus Characterization

Nancy Cox, Ph.D., CDC
11:50
Open Public Hearing 
12:50
Committee Discussion and Recommendations 
1:50
Adjourn for the Day